Magnetic resonance spectroscopy imaging of lactate in patients with bipolar disorder

Psychiatry Research - Neuroimaging

Volumn 213, Issue 3, 2013, Pages 230-234

  Chu, Wen Jang ^a,b   DelBello, Melissa P ^a   Jarvis, Kelly B ^a   Norris, Mathew M ^a   Kim, Mi Jung ^a   Weber, Wade ^a   Lee, Jing Huei ^a,b   Strakowski, Stephen M ^a,b   Adler, Caleb M ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b 705 Engineering Research Center   (United States)

Author keywords

Anterior cingulate cortex; Caudate; Magnetic resonance spectroscopy

Indexed keywords

ARIPIPRAZOLE; CREATINE; LACTIC ACID; LITHIUM; N ACETYLASPARTIC ACID; OXCARBAZEPINE; QUETIAPINE; RISPERIDONE; SERTRALINE; VALPROATE SEMISODIUM; ZIPRASIDONE;

ADULT; ANTERIOR CINGULATE; ANTERIOR COMMISSURE; ARTICLE; BIPOLAR DISORDER; BRAIN LEVEL; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAY MATTER; HUMAN; INSULA; LACTATE BRAIN LEVEL; MALE; MENTAL PATIENT; MIXED MANIA AND DEPRESSION; MONOTHERAPY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL CORTEX; PATIENT POSITIONING; POSTERIOR CINGULATE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SUBSTANCE ABUSE; WHITE MATTER;

EID: 84880714871     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2013.03.004     Document Type: Article

References (33)

1. Boucard C.C., Mostert J.P., Cornelissen F.W., De Keyser J., Oudkerk M., Sijens P.E. Visual stimulation, 1H MR spectroscopy and fMRI of the human visual pathways. European Radiology 2005, 15(1):47-52.
2. Brady, R.O. Jr., Cooper, A., Jensen, J.E., Tandon, N., Cohen, B., Renshaw, P., Keshavan, M., Öngür, D., 2012. A longitudinal pilot proton MRS investigation of the manic and euthymic states of bipolar disorder. Translational Psychiatry 2 (11 September), e160. http://dx.doi.org/10.1038/tp.2012.84.
3. Chu W.J., Kuzniecky R.I., Hugg J.W., Abou-Khalil B., Gilliam F., Faught E., Hetherington H.P. Statistically driven identification of focal metabolic abnormalities in temporal lobe epilepsy with corrections for tissue heterogeneity using 1H spectroscopic imaging. Magnetic Resonance in Medicine 2000, 43:359-367.
4. Corrigan N.M., Richards T.L., Friedman S.D., Petropoulos H., Dager S.R. Improving 1H MRSI measurement of cerebral lactate for clinical applications. Psychiatry Research: Neuroimaging 2010, 182:40-47.
5. Dager S.R., Friedman S.D., Parow A., Demopulos C., Stoll A.L., Lyoo I.K., Dunner D.L., Renshaw P.F. Brain metabolic alterarions in medication-free patients with bipolar disorder. Archives of General Psychiatry 2004, 61:450-458.
6. Domino E.F., Sharp R.R., Lipper S., Ballast C.L., Delidow B., Bronzo M.R. NMR chemistry analysis of red blood cell constituents in normal subjects and lithium-treated psychiatric patients. Biological Psychiatry 1985, 20:1277-1283.
7. Esquivel G., Schruers K.R., Maddock R.J., Colasanti A., Griez E.J. Acids in the brain: a factor in panic?. Journal of Psychapharmacology 2010, 24(5):639-647.
8. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID-I/I, version 2.0, 4/97 version) 1997, Biometrics Research Department, New York State Psychiatric Institute, New York.
9. Friedman S.D., Jensen J.E., Frederick B.B., Artru A.A., Renshaw P.A., Dager S.R. Brain changes to hypocapania using rapidly interleaved phosphorus-proton magnetic resonance spectroscopy at 4T. Journal of Cerebral Blood Flow and Metabolism 2007, 27(3):646-653.
10. Garwood M., DelaBarre L. The return of the frequency sweep: designing adiabatic pulses for contemporary NMR. Journal of Magnetic Resonance Imaging 2001, 153:155-177.
11. Hamakawa H., Murashita J., Yamada N., Inubushi T., Kato N., Kato T. Reduced intracellular pH in the basal ganglia and whole brain measured by 31P-MRS in bipolar disorder. Psychiatry and Clinical Neurosciences 2004, 58:82-88.
12. Hetherington H.P., Pan J.W., Mason G.F., Adams D., Vaughn M.J., Twieg D.B., Pohost G.M. Quantitative 1H spectroscopic imaging of human brain at 4.1T using image segmentation. Magnetic Resonance in Medicine 1996, 36:21-29.
13. Kato T., Kato N. Mitochondrial dysfunction in bipolar disorder. Bipolar Disorders 2000, 2:180-188.
14. Kato T., Kunugi H., Nanko S., Kato N. Association of bipolar disorder with the 5178 polymorphism in mitochondrial DNA. American Journal of Medical Genetics 2000, 96(2):182-186.
15. Kato T. Mitochondrial dysfunction as the molecular basis of bipolar disorder: therapeutic implications. CNS Drugs 2007, 21:1-11.
16. Kim D.J., Lyoo I.K., Yoon S.J., Choi T., Lee B., Kim J.E., Lee J.S., Renshaw P.F. Clinical response of quetiapine in rapid cycling manic bipolar patients and lactate level changes in proton magnetic resonance spectroscopy. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2007, 31:1182-1188.
17. Kirk R., Furlong R.A., Amos W., Cooper G., Rubinsztein J.S., Walsh D., Paykel E.S., Rubinsztein D.C. Mitochondrial genetic analyses suggest selection against maternal lineages in bipolar affective disorder. American Journal of Human Genetics 1999, 65(2):508-518.
18. Konradi C., Eaton M., MacDonald M.L., Walsh J., Benes F.M., Heckers S. Molecular evidence for mitochondrial dysfunction in bipolar disorder. Archives of General Psychiatry 2004, 61:300-308.
19. Kraguljac N.V., Reid M., White D., Jones R., den Hollander J., Lowman D., Lahti A.C. Neurometabolites in schizophrenia and bipolar disorder: a systematic review and meta-analysis. Psychiatry Research: Neuroimaging 2012, 203(2-3):111-125.
20. Lange T., Dydak U., Roberts T.P.L., Rowley H.A., Bjeljac M., Boesinger P. Pitfalls in lactate measurement at 3T. American Journal of Neuroradiology 2006, 27:895-901.
21. Maddock R.J. The lactic acid response to alkalosis in panic disorder: an integrative review. Journal of Neuropsychiatry and Clinical Neuroscience 2001, 13(1):22-34.
22. McMahon F.J., Stine O.C., Meyers D.A., Simpson S.G., DePaulo J.R. Patterns of maternal transmission in bipolar affective disorder. American Journal of Human Genetics 1995, 56(6):1277-1286.
23. Miyasaka N., Takahashi K., Hetherington H.P. 1H NMR spectroscopic imaging of the mouse brain at 9.4T. Journal of Magnetic Resonance Imaging 2006, 24:908-913.
24. Munakata K., Iwamoto K., Bundo M., Kato T. Mitochondrial DNA 3243 A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia. Biological Psychiatry 2005, 57:525-532.
25. Posse S., Otazo R., Dager S.R., Alger J. MR spectroscopic imaging: Principal and recent advances. Journal of Magnetic Resonance Imaging 2013, 37(6):1301-1325.
26. Provencher S.W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Resonance in Medicine 1993, 30:672-679.
27. Regenold W.T., Phatak P., Marano C.M., Sassan A., Conley R.R., Kling M.A. Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesis. Biological Psychiatry 2009, 65:489-494.
28. Reyngoutdt H., Paemeleire K., Dierickx A., Descamps B., Vandemaele P., De Deene Y., Achten E. Does visual cortex lactate increase following photic stimulation in migraine without aura patients? A functional (1)H-MRS study. Journal of Headache Pain 2011, 12(3):295-302.
29. Shahana N., DelBello M., Chu W.-J., Jarvis K., Fleck D., Welge J., Strakowski S., Adler C. Neurochemical alteration in the caudate: implications for the pathology of bipolar disorder. Psychiatry Research: Neuroimaging 2011, 193:107-112.
30. Stork C., Renshaw R.F. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Molecular Psychiatry 2005, 10:900-919.
31. Strakowski S.M., DelBello M.P., Adler C., Cecil K.M., Sax K.W. Neuroimaging in bipolar disorder. Bipolar Disorders 2000, 2:148-164.
32. Strakowski S.M., DelBello M.P., Adler C.M. The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Molecular Psychiatry 2005, 10:105-116.
33. Yildiz-Yesiloglu A., Ankerst D.P. Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings. Progress in Neuropsychopharmacology and Biological Psychiatry 2006, 30(6):969-995.